Proteinuria is a component of preeclampsia, and the presence of proteinuria without an increase in blood pressure can precede preeclampsia. This study aims to investigate the perinatal effects of isolated proteinuria detected in a 24-h urine sample after the 20th week of pregnancy. This is a prospective study of the perinatal outcomes of 60 pregnancies without proteinuria and matched 58 pregnancies with isolated proteinuria in patients consecutively admitted to the department of obstetrics at a university hospital in Turkey. The pregnant patients with proteinuria and without proteinuria were statistically similar with respect to age, gravidity, parity and the number of living children on enrolment. There were no significant differences in terms of gestational age at enrolment, gestational age at delivery, or intrauterine growth restriction (IUGR) between patients with isolated proteinuria and patients without proteinuria. However, preeclampsia developed significantly more frequently in patients with isolated proteinuria (20.6% vs 6.6%, p = 0.048). There were no significant differences in terms of newborn weight, Apgar scores, need for the neonatal intensive care unit (NICU), or umbilical artery blood pH in patients with proteinuria and without proteinuria. Isolated proteinuria after 20 weeks of pregnancy does not appear to impair maternal or foetal outcomes. Identifying pregnant women with risk factors for preeclampsia, ensuring they attend meticulous follow-up schedules and performing their delivery at tertiary health care centres would help to improve maternal and foetal morbidity and prevent perinatal mortality.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Villar J, Say L, Gulmezoglu AM, et al. Eclampsia and pre-eclampsia: a health problem for 2000 years. In: Critchly H, MacLean A, Poston L, Walker J, editors. Preeclampsia. London: RCOG Press; 2003. p. 189–207.
Ronsmans C, Graham WJ. On behalf of the Lancet Maternal Survival Series Steering Group. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189–200.
Roberts CL, Ford JB, Algert CS, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open. 2011;1:e000101.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.
Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016;387(10017):462–74.
Akar ME, Eyi EG, Yilmaz ES, Yuksel B, Yilmaz Z. Maternal deaths and their causes in Ankara, Turkey, 1982–2001. J Health Popul Nutr. 2004;22(4):420–8.
Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the ACOG’s Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.
Dubowitz LM, Dubowitz V, Goldberg C. Clinical assesment of gestational age in the newborn. J Pediatr. 1970;77:1–10.
Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008;199:36.e1–5.
Harmon QE, Huang L, Umbach DM, Klungsøyr K, Engel SM, Magnus P, et al. Risk of fetal death with preeclampsia. Obstet Gynecol. 2015;125(3):628–35.
Cunningham FG, Leveno KJ, Bloom SL, et al. Hypertensive disorders of pregnancy. In:Willams Obstetrics. 24th ed. New York: McGraw-Hill; 2014. p. 728–80.
Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22:203–12.
Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining preeclampsia: clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010;37(4):466–70.
Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe pre-eclampsia. Am J Obstet Gynecol. 1996;175:1313–6.
Maybury H, Waugh J. Proteinuria in pregnancy: just what is significant? Fetal Matern Med Rev. 2004;16:71–95.
Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol. 1990;162:366–71.
Lindheimer, Marshall D, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol. 2010;115(2 Part 1):365–75.
The authors declare that they have no competing interests.
The BEU Ethics Committee approved the study (2014-51-25/02).
Taken from the patients.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Surgery
About this article
Cite this article
Özdemir, O., Arıkan, İ.İ., Sel, G. et al. The Effects of Isolated Proteinuria Detected After 20 Weeks of Pregnancy on Perinatal Outcomes. SN Compr. Clin. Med. 2, 1661–1665 (2020). https://doi.org/10.1007/s42399-020-00419-5